Amphastar Pharmaceuticals (AMPH) - Cash per Share

Corporate emblem and logo of Amphastar Pharmaceuticals (AMPH)

Amphastar Pharmaceuticals dominates the complex inhalation and injectable segment, leveraging low mass-production costs. The current cash per share confirms financial strength, as the parameter has stabilized at 5.46. This stability is bolstered by the development of biosimilars and innovative drug delivery systems, as well as operating leverage that significantly reduces costs as production volumes increase.

amphastar.com (AMPH) Cash per Single Share: for the period 07/04/2022 - 11/20/2026

Analytical breakdowns for Amphastar Pharmaceuticals

- cash position and cash flow details:
General company analysis:Amphastar Corp - AMPH
Core merchandise of amphastar.com

To objectively assess the operational efficiency of Amphastar Pharmaceuticals (AMPH), investors must understand the actual volume of liquidity available for business development. By analyzing the cash per share metric via the GURU.Markets platform, you can see the ratio of cash holdings to the number of shares, which confirms the company's ability to fund expansion within the complex injectable drug niche and maintain margins when acquiring new brands.

Analysis of competing companies

Cash on Hand per Share Haleon Corp HLN|Cash per Single Share KVUE (Kenvue Health)|Verona Pharma plc - Cash Funds per Single Share|Jyong Biotech - Cash per Single Share|LGND: Cash Funds per Single Share|AMRX: Cash per Single Share|Cash on Hand per Share Perrigo Company plc|ALVO: Cash per Share|Liquidia (LQDA) - Cash per Share|Cash Funds per Share Galapagos N.V.|Cash per Single Share ANI Pharmaceuticals, Inc. (ANIP)|Cash per Share MNKD|PCRX - Cash on Hand per Share|Cash per Share SPRY (ars-pharma.com)|Amount of Cash per Share TBPH|Aquestive Therapeutics, Inc. - Cash per Share|scpharmaceuticals.com - Cash Calculated per Single Share|Tectonic (TECX) - Cash Funds per Share|Cash per Single Share Tonix Pharmaceuticals Inc.|Cash Funds per Share sxtchina.com|Cash per Single Share Eupraxia Pharmaceuticals (EPRX)|Cash per Share BHST|EXOZ - Cash on Hand per Share|Oramed - Cash per Single Share|Entera Bio Ltd. (ENTX) - Cash on Hand per Share|HYFT - Cash Funds per Share|ABVC: Cash Funds per Share|CPIX: Cash per Share|Quantum BioPharma Ltd. - Amount of Cash per Share|FGEN (FibroGen Corp) - Cash per Share|Telomir Pharma (TELO) - Cash Funds Calculated per Share|Cash Funds per Share Rani Therapeutics Inc (RANI)|SNYR (Synergy CHC Corp.) - Amount of Cash per Share|Cash Funds per Share Rallybio Corporation RLYB|LEXX: Cash Funds per Single Share|PULM - Cash Funds per Share|Amount of Cash per Share PTHL (Pheton Holdings)|Aptorum (APM) - Cash Funds per Share|LYRA (Lyra Therapeutics) - Cash Funds per Share|Cash Funds per Share Impact BioMedical Inc|TNF Pharmaceuticals - Cash Money per Share|Cash per Share YCBD|Cash per Share PainReform Ltd. (PRFX)|Cash Funds per Share Altamira Therapeutics Ltd CYTO|LIPO (lipella.com) - Cash Money per Share|OptiNose - Cash per Share|Cash Money per Share PIRS|PROC: Cash per Share|Petros - Amount of Cash per Share|Cash per Single Share QLI|SLRN: Amount of Cash per Share|Cash per Single Share TFFP (TFF Pharmaceuticals, Inc.)